US Stock MarketDetailed Quotes

TARS Tarsus Pharmaceuticals

Watchlist
  • 26.480
  • -0.800-2.93%
Trading Jun 20 13:48 ET
1.00BMarket Cap-5574P/E (TTM)

Tarsus Pharmaceuticals Key Stats

Tarsus Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 8, 2024

Revenue(YoY)

27.61M

+1004.56%
EPS(YoY)

-1.01

-14.77%

Strong Buy

Jun 20, 2024

Tarsus Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 39.184M--
--2024/Q2-- / 32.375M--
May 8, 20242024/Q127.614M / 17.898M--
Feb 27, 20242023/Q413.076M / 5.924M--
Nov 9, 20232023/Q31.871M / 361.000K--
--2023/Q20.000 / 0.000--
--2023/Q12.500M / 3.333M--
--2022/Q410.000M / 10.000M--
--2022/Q30.000 / 3.500M--
--2022/Q215.277M / 11.250M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 39.184M--
--2024/Q2-- / 32.375M--
May 8, 20242024/Q127.614M / 17.898M--
Feb 27, 20242023/Q413.076M / 5.924M--
Nov 9, 20232023/Q31.871M / 361.000K--
--2023/Q20.000 / 0.000--
--2023/Q12.500M / 3.333M--
--2022/Q410.000M / 10.000M--
--2022/Q30.000 / 3.500M--
--2022/Q215.277M / 11.250M--

Unlock Free Earnings Estimates

Tarsus Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Jun 20, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg